Frontlight ResearchEarly access
Trial site
Salve Medica Sp. z o.o. S.K.
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Heart failure2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- High blood pressure1 trial
- Long COVID and ME/CFS1 trial
- Metastatic breast cancer1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- AstraZeneca1 trial
- Medical University Of Gdansk1 trial
- Merck Sharp & Dohme LLC1 trial
- Novo Nordisk A/S1 trial
- Poznan University of Medical Sciences1 trial
- and 1 more
Running trials
Recruiting
Recruiting
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
Active, not recruiting
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026